Divis Laboratories’ unit undergoes inspection by US-FDA

03 Aug 2011 Evaluate

Divis Laboratories’ unit-1 at vill., Lingojigudem, Choutuppal Mandal near Hyderabad had been inspected by the US-FDA. The intention of this inspection was for product pre-approval and general current good manufacturing practices. The audit concluded with minor observations primarily about additional records for further improvement of existing records.

The company has registered a growth of 26.55% in its net profit for the year ended March 31, 2011 at Rs 435.57 crore as compared to Rs 344.20 crore for the year ended March 31, 2010. Its total income has increased by 40.00% at Rs 1344.04 crore for the year from Rs 959.98 crore in previous year.

Divis Lab Share Price

3923.85 11.95 (0.31%)
18-May-2024 11:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.15
Dr. Reddys Lab 5827.40
Cipla 1402.20
Zydus Lifesciences 1104.45
Lupin 1663.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.